A golden year for Wall Street’s Australian stock picker

Matthew McLennan’s $14.5 billion position in gold bars and miners paid off handsomely for First Eagle this year. But he insists the precious metal still has room to run.
Matthew McLennan in his office at First Eagle Investments in New York. Picture: Jaclyn Licht

Jonathan Shapiro

A golden year for Wall Street’s Australian stock picker

July 7, 2025
Matthew McLennan’s $14.5 billion position in gold bars and miners paid off handsomely for First Eagle this year. But he insists the precious metal still has room to run.
Read Transcript

Of all the Australians who have made a name for themselves on Wall Street, Matthew McLennan can surely lay claim to be among the most prominent.

Born in Papua New Guinea and raised in Queensland, McLennan landed in New York via Sydney and London and is now the co-head of First Eagle’s global value team, overseeing the asset manager’s $US62.3 billion ($94.7 billion) global fund.

It’s far from your typical equities fund. In fact, more than 10 per cent of the portfolio is invested, not in stocks, but gold bullion. In addition, the fund has stakes in listed gold miners which lifts its total exposure to the precious metal to more than 14.5 per cent.

And in a year in which gold has been among the hottest commodities, it’s a position that has paid off for investors in the fund, which returned 19.07 per cent in the 12 months to July 1.

“The reason we own gold is it’s the embodiment of scarcity value,” McLennan tells The Australian Financial Review ahead of his appearance at the Sohn Hearts & Minds charity conference in November this year.

“You can create more nominal claims on a sovereign entity, but gold is relatively fixed in supply, and so it’s a good potential hedge against that nominal drift accelerating in the economy.”

In other words, gold is there to protect value in times when central banks are pumping the global economy with money or governments are flooding it with debt.

But is the rally in gold near its peak? McLennan doesn’t think so.

“I would argue that gold has recovered from depressed levels relative to equities, and depressed levels relative to the stock of government debt, to more rational price levels.”

McLennan insists he’s not a “gold bug” and in April amid the market rout, he was trimming the fund’s gold exposure to buy beaten-down stocks.

In fact, the past year has been unusual in that both stocks and gold have enjoyed a solid rally which has meant the precious metal hasn’t just protected the portfolio but enhanced it.

The global sharemarket gained 16.7 per cent, but the gold price jumped 42 per cent and the index of gold miners was even higher at 55.3 per cent.

For McLennan, the dual rise in stocks and gold is a “very important price signal in markets”.

“What it tells you is that the real value of money has gone down. The market is making a judgment that real assets, in aggregate, are worth more, and the symmetry of that is that there’s an expected greater supply of fixed nominal assets.”

By fixed nominal assets, he means bonds, and in particular government bonds. The worry he shares with the market is that we’re getting closer to the limits of how much money governments can borrow, and ultimately repay.

If the 1990s was a crisis in corporate debt, and the 2000s a crisis centred on household debt, “the emergent risk for the decade ahead has been sovereign in nature”.

McLennan is also concerned that United States indebtedness is high at a time when most Americans have jobs, and the country will lack the capacity to borrow what it needs if the economy turns.

In time, the market is going to demand higher interest rates to lend to the government either because inflation goes up or the risk of default or debasement goes up.

“The absence of a risk-free rate is global in nature, and it’s an interesting backdrop for what’s going on in markets at the moment,” the fund manager adds.


Risk of complacency


For now, the market appears to have set aside its worries about how the US will be able to finance its deficit as sharemarkets are back at record highs and corporate debt spreads have contracted to their lowest levels since the global financial crisis.

“When you have easy financial conditions, low credit spreads, high multiples, there’s less asymmetry between price and prospects,” McLennan says.

“Prospects can improve, but you’re already pricing some improvement. So, I think there may be a risk of complacency in risk assets.”

And if the next six months is as eventful as the last, the market’s confidence is set to be shaken again.

“If there’s one commodity, the market’s short of its patience.”

McLennan was first hired at Goldman Sachs in Sydney in 1994 before he eventually found his way to London where he ran a global equity fund for the firm’s private clients.

In September 2008 just as Lehman Brothers was collapsing, and the global financial system was on the brink, McLennan joined First Eagle, a firm with a heritage that dates back to the 1800s.

The timing was hardly ideal, but the real challenge was to come. Because the value style of investing, which can broadly be defined as buying stocks on low valuations, has been out of favour ever since.

Since January 2009, the MSCI value factor has lagged the global index while the MSCI growth factor is 43 per cent ahead.

“The essence of a value mindset is that you see risk as a permanent impairment of capital. For us, our primary objective as investors is to avoid the permanent impairment of capital.”

McLennan says the traditional value investing approach of buying the cheapest stocks based on certain crude measures left investors exposed to “adverse selection risk”. In other words, they may end up owning businesses with weak market positions, vulnerable balance sheets and poor management.

“We have to feel comfortable with a business first before we assess value,” he adds. “Ultimately, you have to feel comfortable that there’s some persistence to the cash flow stream and some integrity to the positional attributes of the business before you can capitalise earnings.”

Among First Eagle’s largest current holdings are Meta, Oracle, HCA Healthcare and Philip Morris.

The 56-year-old has managed to survive and flourish on Wall Street for three decades. So, what’s his secret?

Patience, he says.

“If there’s one commodity, the market’s short of its patience. Having a patient temperament enables you to weather protracted windows where your approach might be short on social acceptance.

“It helps you stick to a philosophy, even though there may be fads in between that lead other people into what turn out to be dead ends.”

Another essential quality in funds management is humility, he adds.

“The reality is that much of what you’ve learned in business school is how to model statistical risk. But the truth is, a complex system like the world economy is much better described by uncertainties.

“You just have to be open-minded to the fact that the reality can be quite strange. If you construct portfolios that can be robust in hard-to-imagine scenarios that gives you some staying power.”

The Sohn Hearts & Minds takes place at the Sydney Opera House on Friday, November 14, 2025. The Australian Financial Review is a media partner and tickets can be purchased here.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Of all the Australians who have made a name for themselves on Wall Street, Matthew McLennan can surely lay claim to be among the most prominent.

Born in Papua New Guinea and raised in Queensland, McLennan landed in New York via Sydney and London and is now the co-head of First Eagle’s global value team, overseeing the asset manager’s $US62.3 billion ($94.7 billion) global fund.

It’s far from your typical equities fund. In fact, more than 10 per cent of the portfolio is invested, not in stocks, but gold bullion. In addition, the fund has stakes in listed gold miners which lifts its total exposure to the precious metal to more than 14.5 per cent.

And in a year in which gold has been among the hottest commodities, it’s a position that has paid off for investors in the fund, which returned 19.07 per cent in the 12 months to July 1.

“The reason we own gold is it’s the embodiment of scarcity value,” McLennan tells The Australian Financial Review ahead of his appearance at the Sohn Hearts & Minds charity conference in November this year.

“You can create more nominal claims on a sovereign entity, but gold is relatively fixed in supply, and so it’s a good potential hedge against that nominal drift accelerating in the economy.”

In other words, gold is there to protect value in times when central banks are pumping the global economy with money or governments are flooding it with debt.

But is the rally in gold near its peak? McLennan doesn’t think so.

“I would argue that gold has recovered from depressed levels relative to equities, and depressed levels relative to the stock of government debt, to more rational price levels.”

McLennan insists he’s not a “gold bug” and in April amid the market rout, he was trimming the fund’s gold exposure to buy beaten-down stocks.

In fact, the past year has been unusual in that both stocks and gold have enjoyed a solid rally which has meant the precious metal hasn’t just protected the portfolio but enhanced it.

The global sharemarket gained 16.7 per cent, but the gold price jumped 42 per cent and the index of gold miners was even higher at 55.3 per cent.

For McLennan, the dual rise in stocks and gold is a “very important price signal in markets”.

“What it tells you is that the real value of money has gone down. The market is making a judgment that real assets, in aggregate, are worth more, and the symmetry of that is that there’s an expected greater supply of fixed nominal assets.”

By fixed nominal assets, he means bonds, and in particular government bonds. The worry he shares with the market is that we’re getting closer to the limits of how much money governments can borrow, and ultimately repay.

If the 1990s was a crisis in corporate debt, and the 2000s a crisis centred on household debt, “the emergent risk for the decade ahead has been sovereign in nature”.

McLennan is also concerned that United States indebtedness is high at a time when most Americans have jobs, and the country will lack the capacity to borrow what it needs if the economy turns.

In time, the market is going to demand higher interest rates to lend to the government either because inflation goes up or the risk of default or debasement goes up.

“The absence of a risk-free rate is global in nature, and it’s an interesting backdrop for what’s going on in markets at the moment,” the fund manager adds.


Risk of complacency


For now, the market appears to have set aside its worries about how the US will be able to finance its deficit as sharemarkets are back at record highs and corporate debt spreads have contracted to their lowest levels since the global financial crisis.

“When you have easy financial conditions, low credit spreads, high multiples, there’s less asymmetry between price and prospects,” McLennan says.

“Prospects can improve, but you’re already pricing some improvement. So, I think there may be a risk of complacency in risk assets.”

And if the next six months is as eventful as the last, the market’s confidence is set to be shaken again.

“If there’s one commodity, the market’s short of its patience.”

McLennan was first hired at Goldman Sachs in Sydney in 1994 before he eventually found his way to London where he ran a global equity fund for the firm’s private clients.

In September 2008 just as Lehman Brothers was collapsing, and the global financial system was on the brink, McLennan joined First Eagle, a firm with a heritage that dates back to the 1800s.

The timing was hardly ideal, but the real challenge was to come. Because the value style of investing, which can broadly be defined as buying stocks on low valuations, has been out of favour ever since.

Since January 2009, the MSCI value factor has lagged the global index while the MSCI growth factor is 43 per cent ahead.

“The essence of a value mindset is that you see risk as a permanent impairment of capital. For us, our primary objective as investors is to avoid the permanent impairment of capital.”

McLennan says the traditional value investing approach of buying the cheapest stocks based on certain crude measures left investors exposed to “adverse selection risk”. In other words, they may end up owning businesses with weak market positions, vulnerable balance sheets and poor management.

“We have to feel comfortable with a business first before we assess value,” he adds. “Ultimately, you have to feel comfortable that there’s some persistence to the cash flow stream and some integrity to the positional attributes of the business before you can capitalise earnings.”

Among First Eagle’s largest current holdings are Meta, Oracle, HCA Healthcare and Philip Morris.

The 56-year-old has managed to survive and flourish on Wall Street for three decades. So, what’s his secret?

Patience, he says.

“If there’s one commodity, the market’s short of its patience. Having a patient temperament enables you to weather protracted windows where your approach might be short on social acceptance.

“It helps you stick to a philosophy, even though there may be fads in between that lead other people into what turn out to be dead ends.”

Another essential quality in funds management is humility, he adds.

“The reality is that much of what you’ve learned in business school is how to model statistical risk. But the truth is, a complex system like the world economy is much better described by uncertainties.

“You just have to be open-minded to the fact that the reality can be quite strange. If you construct portfolios that can be robust in hard-to-imagine scenarios that gives you some staying power.”

The Sohn Hearts & Minds takes place at the Sydney Opera House on Friday, November 14, 2025. The Australian Financial Review is a media partner and tickets can be purchased here.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Jul 07, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 14, 2025

$1.4 million boost for SA medical research

South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.

Read More
Anthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. APAnthony Scaramucci’s time in the White House was brief but memorable. AP
May 19, 2025

Why ‘The Mooch’ thinks Trump is more dangerous this time around

Anthony Scaramucci says Trump has fewer constraints on his worst instincts in his second administration. But he still gets bored easily.

Read More
Image caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn LichtImage caption: Anthony “The Mooch” Scaramucci at the New York headquarters of his SkyBridge Capital last week. Picture: Jaclyn Licht
May 19, 2025

My biggest mistake: Anthony Scaramucci on what makes Donald Trump tick

On Elon Musk, money and the White House, fast-talking Wall Street hedge fund manager and former Trump communications director Anthony Scaramucci tells it as he sees it.

Read More
A bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFPA bull case for Bitcoin even as it trades near record levels. Picture: AFP
May 19, 2025

Bitcoin ‘on track’ for $US200,000: Anthony Scaramucci

Bitcoin could hit as much as $US200,000 ($311,000) by the end of this year, fuelled by surging inflows into exchange-traded funds and Donald Trump’s erratic policymaking.

Read More
Anthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn LichtAnthony Scaramucci says America has no choice but to lower tariffs on China further. Jaclyn Licht
May 19, 2025

‘The Mooch’ says Trump will have to cut China tariffs below 10pc

Scaramucci, who is best known as The Mooch, is the first big-name global investor to be confirmed for the Sohn Hearts & Minds conference in Sydney in November.

Read More
Stillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn LichtStillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn Licht
September 25, 2025

Stillpoint founder Eric Wong reveals major China tech investment strategy

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.

Read More
October 1, 2025

Billionaire hedge fund manager enacts ‘little short’ on the market

Investing veteran Lord Michael Hintze says he’s taking out insurance against expensive debt and equity markets that are being propelled by passive flows.

Read More
October 1, 2025

Hedge fund guru Michael Hintze can't out-trade machines but he can still 'out-invest' them

Billionaire hedge fund manager Michael Hintze says the world is more dangerous than he has ever seen, artificial intelligence is stifling people’s ability to learn and process information.

Read More
Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.Marathon Resource Advisors founder and chief investment officer Robert Mullin in San Francisco.
October 5, 2025

Marathon CIO Robert Mullin reveals why gold stocks are still undervalued

The son of a stockbroker, Mr Mullin has more than 30 years' investing experience and is chief investment officer at Marathon Resource Advisors in San Francisco, a company he founded.

Read More
First Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn LichtFirst Eagle Investments co-head of global value Matthew McLennan. Picture: Jaclyn Licht
October 6, 2025

First Eagle’s Matthew McLennan on the monetary force that could be ‘rocket fuel’ for the Australian dollar

Matthew McLennan, the co-head of the global value team and portfolio manager at the $US161bn ($243bn) First Eagle Investments, stormed the market with a bullish bet on gold.

Read More
October 10, 2025

Anthony Scaramucci’s advice to our PM is to seek his Canadian counterpart’s counsel

Beyond Wall Street, The Mooch is better known for his cutting takes on US politics in the popular podcast The Rest is Politics: US, which he hosts with BBC’s long-term North American correspondent Katty Kay.

Read More
October 19, 2025

Munro Partners' Qiao Ma reveals AI investment strategy

Qiao Ma has a simple test for spotting the investment opportunities that will define the next decade. Take the technology apart and see what’s inside.

Read More
October 21, 2025

Meet the 2025 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2025.

Read More
October 31, 2025

The 42pc gain that shows why Sohn is a stock picker’s delight

It turns out you could have outperformed the seemingly unstoppable magnificent seven tech stocks if you simply acted on the 11 stock picks at Sohn last year.

Read More
November 3, 2025

How to beat the market without owning Nvidia shares

Vihari Ross' global fund returned more than 20 per cent in the year to September 30 versus about 10 per cent for the benchmark without owning Nvidia, Meta, Tesla, Apple or Broadcom.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.